MabCure, Inc.
MBCI
$0.0001
$0.000.00%
OTC PK
| 12/31/2011 | 09/30/2011 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 16.80% | -9.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.55% | -16.40% | |||
| Operating Income | 185.00% | 16.40% | |||
| Income Before Tax | -3,957.47% | 33.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -3,957.47% | 33.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3,957.47% | 33.04% | |||
| EBIT | 185.00% | 16.40% | |||
| EBITDA | 189.19% | 16.34% | |||
| EPS Basic | -3,965.12% | 33.85% | |||
| Normalized Basic EPS | 177.78% | 34.15% | |||
| EPS Diluted | -3,965.12% | 33.85% | |||
| Normalized Diluted EPS | 177.78% | 34.15% | |||
| Average Basic Shares Outstanding | 0.79% | 0.54% | |||
| Average Diluted Shares Outstanding | 0.79% | 0.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||